Health CarePharmaceuticals and Biotechnology
  • Price (USD)41.84
  • Today's Change-0.02 / -0.05%
  • Shares traded772.58k
  • 1 Year change+2.02%
  • Beta0.9111
Data delayed at least 15 minutes, as of Aug 16 2022 21:10 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Tuesday, Perrigo Company PLC (PRGO:NYQ) closed at 41.84, -17.80% below its 52-week high of 50.90, set on Sep 30, 2021.
52-week range
31.32May 10 202250.90Sep 30 2021
Markit short selling activity
Previous close41.84
Average volume1.61m
Shares outstanding134.54m
Free float133.71m
P/E (TTM)--
Market cap5.62bn USD
EPS (TTM)-0.655
Annual div (ADY)1.04
Annual div yield (ADY)2.48%
Div ex-dateJun 02 2022
Div pay-dateJun 21 2022
Next div ex-dateSep 01 2022
Next div pay-dateSep 20 2022
Data delayed at least 15 minutes, as of Aug 16 2022 21:10 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.